United Purification Technology Co., Ltd.
United Purification Technology Co., Ltd., together with its subsidiaries, designs, plans, assemblies, manufactures, sells and installs pure/recycled water equipment in Taiwan and Mainland China. It also engages in machinery and equipment repair and installation; motor repair; and ESG coaching planning and implementation activities. The company's products are used in semiconductor/electronics fact… Read more
United Purification Technology Co., Ltd. (6977) - Total Liabilities
Latest total liabilities as of June 2025: NT$1.14 Billion TWD
Based on the latest financial reports, United Purification Technology Co., Ltd. (6977) has total liabilities worth NT$1.14 Billion TWD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
United Purification Technology Co., Ltd. - Total Liabilities Trend (2020–2024)
This chart illustrates how United Purification Technology Co., Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
United Purification Technology Co., Ltd. Competitors by Total Liabilities
The table below lists competitors of United Purification Technology Co., Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Financeira Alfa S.A. - Crédito Financiamento e Investimentos
SA:CRIV3
|
Brazil | R$16.29 Billion |
|
Northern Ocean Ltd
PINK:NTNOF
|
USA | $662.45 Million |
|
Sriracha Construction Public Company Limited
BK:SRICHA
|
Thailand | ฿1.58 Billion |
|
Mereo BioPharma Group plc
F:MAH0
|
Germany | €7.00 Million |
|
Thaivivat Holdings Public Company Limited
BK:TVH
|
Thailand | ฿5.50 Billion |
|
OSE Immunotherapeutics S.A.
LSE:0RAD
|
UK | €45.91 Million |
|
1895 of Wisconsin Inc Bancorp
NASDAQ:BCOW
|
USA | $546.41 Million |
|
Helius Medical Technologies Inc Class A
NASDAQ:HSDT
|
USA | $628.31 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down United Purification Technology Co., Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.67 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how United Purification Technology Co., Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for United Purification Technology Co., Ltd. (2020–2024)
The table below shows the annual total liabilities of United Purification Technology Co., Ltd. from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$482.65 Million | +19.52% |
| 2023-12-31 | NT$403.83 Million | -14.69% |
| 2022-12-31 | NT$473.38 Million | +43.21% |
| 2021-12-31 | NT$330.56 Million | +26.08% |
| 2020-12-31 | NT$262.18 Million | -- |